Impact of Season and Other Factors on Initiation, Discontinuation, and Switching of Systemic Drug Therapy in Patients with Psoriasis: A Retrospective Study.

Liang, Huifang; Kirk, Brenna; Polinski, Jennifer M; Yue, Xiaomeng; Kilpatrick, Ryan D; Gelfand, Joel M

Liang, Huifang; Kirk, Brenna; Polinski, Jennifer M; Yue, Xiaomeng; Kilpatrick, Ryan D; Gelfand, Joel M.

Afiliação

Liang H; Global Epidemiology, Pharmacovigilance and Patient Safety, AbbVie, North Chicago, Illinois, USA.
Kirk B; Aetion, Boston, Massachusetts, USA.
Polinski JM; Aetion, Boston, Massachusetts, USA.
Yue X; Global Epidemiology, Pharmacovigilance and Patient Safety, AbbVie, North Chicago, Illinois, USA.
Kilpatrick RD; Global Epidemiology, Pharmacovigilance and Patient Safety, AbbVie, North Chicago, Illinois, USA.
Gelfand JM; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

JID Innov ; 3(2): 100171, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36876219

Palavras-chave

CED, cohort entry date; CI, confidence interval; ICD, International Classification of Diseases; PsA, psoriatic arthritis; RR, relative rate; US, United States

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: JID Innov Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google